BMC Cancer

1. SHASH E, Vardar MA, Taskiran C, Boujassoum S, et al
   Homologous recombination deficiency in newly diagnosed advanced ovarian cancer across nine Middle East countries: prevalence, real-world testing pathways, and treatment implications.
   BMC Cancer. 2026 Feb 4. doi: 10.1186/s12885-025-15537.
   

   >> Share

   
   

   
   Cancer Lett

2. ZHAO Q, Yao Y, Liang T, Chen M, et al
   Neutrophil Extracellular Traps Enhance Platinum Resistance in Ovarian Cancer via SHP-1 Activation.
   Cancer Lett. 2026 Jan 29:218288. doi: 10.1016/j.canlet.2026.218288.
   

   >> Share

   
   

   
   Gynecol Oncol

3. PEREZ L, Kulkarni A, Lopez S, Brewer JT, et al
   Understanding patient priorities: Sexual health and hereditary ovarian cancer syndromes.
   Gynecol Oncol. 2026;205:113-119.
   

   >> Share

   
   

   
   Int J Gynecol Pathol

4. TANOGLU FB, Karakus SS, Karakus R, Akgun N, et al
   Endometrioma and Mature Cystic Teratoma as Collision Tumors of the Ovary: A Case Series and Literature Review.
   Int J Gynecol Pathol. 2026;45:142-151.
   

   >> Share

   
   
5. MITRA S, Mandal A
   Sex Cord-like Endometrioid Carcinoma Arising From Broad Ligament, a Challenging Diagnosis: Report of 2 Cases.
   Int J Gynecol Pathol. 2026;45:175-180.
   

   >> Share

   
   
6. SMITH SH, Hinchcliff E, Felicelli C
   EML4::NTRK3 Rearranged Ovarian Neoplasm: Case Report and Literature Review.
   Int J Gynecol Pathol. 2026;45:170-174.
   

   >> Share

   
   
7. LEINO A, Nostolahti A, Ahtikoski A, Huvila J, et al
   Molecular Subtype and Mutational Profile of Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia.
   Int J Gynecol Pathol. 2026;45:120-128.
   

   >> Share

   
   

   
   Oncogene

8. VISWANADHAPALLI S, Lee TK, Elmore S, Sharma G, et al
   Therapeutic optimization of LIPA targeting to induce endoplasmic reticulum stress and cell death in ovarian cancer.
   Oncogene. 2026 Feb 6. doi: 10.1038/s41388-026-03689.
   

   >> Share

   
   

   
   PLoS One

9. MRKVICOVA A, Slavickova M, Peterova E, Melounkova L, et al
   Stemness and EMT profiles shift in xenografts derived from cisplatin-sensitive and cisplatin-tolerant ovarian cancer cells.
   PLoS One. 2026;21:e0342326.
   

   >> Share

   
   
10. LI F, Jia Y, Min X, Zhang P, et al
    WNK2 may promote ovarian cancer progression by upregulating POU5F1B.
    PLoS One. 2026;21:e0332003.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share